Lode Debrabandere

All filings by Lode Debrabandere on record concern Osiris Therapeutics, Inc. Between 14 May 2009 and 20 November 2015, the trades on record add up to 3 filings.

On the market, this insider has only sold: 1 sale, €347k in total. Outside the open market, there are 2 option exercises.

On 20 November 2015 came the latest disclosure, an option exercise for €239k in Osiris Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.